אטורבסטאטין טבע ® 40 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

ATORVASTATIN AS CALCIUM 40 MG

Verfügbar ab:

TEVA PHARMACEUTICAL INDUST.LTD

ATC-Code:

C10AA05

Darreichungsform:

TABLETS

Verabreichungsweg:

PER OS

Hergestellt von:

TEVA PHARMACEUTICAL INDUSTRIES LTD

Therapiegruppe:

ATORVASTATIN

Anwendungsgebiete:

Atorvastatin Teva is indicated as an adjunct to diet for reduction of elevated total cholesterol LDL- cholesterol apolipoprotein B and triglycerides and to increase HDL Cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types IIa and IIb of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. Atorvastatin Teva is also indicated to reduce total-C and LDL -C in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. LDL apheresis) or if such treatments are unavailable. Pediatric patients (10-17 years of age) : Atorvastatin is indicated as an adjunct to diet to reduce total -C LDL-C and apo B levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. LDL

Berechtigungsdatum:

2010-05-01